Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Rizatriptan Treatment Report
What is Rizatriptan?

Rizatriptan is an antimigraine agent available under the brand names Maxalt-MLT®; Maxalt®. It is used in the treatment of acute treatment of migraine with or without aura.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell 		# of patients evaluated by
Other 1 1
Migraine Headaches 1 0
Migraine 1 1

See all 2 patients currently taking Rizatriptan

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
2 100%

Dosages

  10mg as needed 5mg as needed
  1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Rizatriptan (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense
1 100% Expense: 100%

See all 1 patient who’ve stopped taking Rizatriptan

Duration See details about how long patients take this treatment ▼

Currently Taking Rizatriptan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Rizatriptan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
1 50%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 16, 2010.